A Review of the LARIAT Suture Delivery Device for Left Atrial Appendage Closure

The prevalence of atrial fibrillation (AF) is 1-2 % in the general population, and the risk of embolic stroke in AF patients is 4-5 times higher than that in the general population. AF-related strokes are often severe, and the rate of permanent disability is much higher among individuals who have AF-related strokes than in those who have strokes unrelated to AF. In patients with AF, more than 90 % of thrombi originate from the left atrial appendage (LAA). The purpose of this paper is to review the efficacy and safety of performing the LAA closure with the LARIAT Suture Delivery Device to prevent AF-related stroke in patients with contraindications to oral anticoagulant therapy.

[1]  M. Price,et al.  Early safety and efficacy of percutaneous left atrial appendage suture ligation: results from the U.S. transcatheter LAA ligation consortium. , 2014, Journal of the American College of Cardiology.

[2]  D. Walters,et al.  Non-Pharmacological Therapy for Atrial Fibrillation: Managing the Left Atrial Appendage , 2012, Cardiology research and practice.

[3]  M. Ezekowitz,et al.  2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. , 2014, Circulation.

[4]  A. Leal,et al.  Thrombus formation on a left atrial appendage closure device. , 2011, Circulation.

[5]  A. Pershad,et al.  Early results with the LARIAT device for left atrial appendage exclusion in patients with atrial fibrillation at high risk for stroke and anticoagulation , 2015, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[6]  A. Massumi,et al.  Initial experience with a novel percutaneous left atrial appendage exclusion device in patients with atrial fibrillation, increased stroke risk, and contraindications to anticoagulation. , 2013, The American journal of cardiology.

[7]  C. Wolfe,et al.  Characteristics, Outcome, and Care of Stroke Associated With Atrial Fibrillation in Europe: Data From a Multicenter Multinational Hospital–Based Registry (The European Community Stroke Project) , 2001, Stroke.

[8]  D. Singer,et al.  Recent national patterns of warfarin use in atrial fibrillation. , 1998, Circulation.

[9]  Dhanunjaya R. Lakkireddy,et al.  Left atrial appendage occlusion: opportunities and challenges. , 2014, Journal of the American College of Cardiology.

[10]  D. Singer,et al.  Warfarin Use among Ambulatory Patients with Nonvalvular Atrial Fibrillation: The AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study , 1999, Annals of Internal Medicine.

[11]  K. Ellenbogen,et al.  LAA ligation using the LARIAT suture delivery device: tips and tricks for a successful procedure. , 2014, Heart rhythm.

[12]  A. Camm,et al.  Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). , 2010, European heart journal.

[13]  P. Wolf,et al.  Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. , 1991, Stroke.

[14]  Jeroen J. Bax,et al.  Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). , 2010, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[15]  G. Lip,et al.  Atrial Fibrillation and the Hypercoagulable State: From Basic Science to Clinical Practice , 2003, Pathophysiology of Haemostasis and Thrombosis.

[16]  A. Massumi,et al.  Cryoballoon Pressure Waveform Change during Balloon Inflation is not a Reliable Predictor of Adequate Pulmonary Vein Occlusion , 2014, Pacing and clinical electrophysiology : PACE.

[17]  M. Ezekowitz,et al.  2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. , 2014, Circulation.

[18]  P. Wolf,et al.  Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study. , 1987, Archives of internal medicine.

[19]  Gregory Y H Lip,et al.  The global burden of atrial fibrillation and stroke: a systematic review of the epidemiology of atrial fibrillation in regions outside North America and Europe. , 2012, Chest.

[20]  Frederick T. Han,et al.  Percutaneous left atrial appendage suture ligation using the LARIAT device in patients with atrial fibrillation: initial clinical experience. , 2013, Journal of the American College of Cardiology.